Ornithine transcarbamylase deficiency: Pathogenesis of the cerebral disorder and new prospects for therapy

Metabolic Brain Disease

Volumn 12, Issue 3, 1997, Pages 171-182

  Michalak, Adrianna ^a   Butterworth, Roger F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Gene therapy; Hyperammonemia; Liver transplantation; Ornithine Transcarbamylase Deficiency; Urea cycle enzyme

Indexed keywords

ORNITHINE CARBAMOYLTRANSFERASE;

ANIMAL MODEL; ENZYME DEFICIENCY; GENE THERAPY; HYPERAMMONEMIA; LIVER TRANSPLANTATION; MENTAL DEFICIENCY; MOUSE; MUSCLE HYPOTONIA; NONHUMAN; REVIEW; SEIZURE; UREA CYCLE;

ANIMALS; BRAIN; BRAIN DISEASES; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, MUTANT STRAINS; ORNITHINE CARBAMOYLTRANSFERASE;

ANIMALIA;

EID: 0030864157     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000007098.80372.68     Document Type: Review

References (60)

1. Anholt, R.R.H. (1986). Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism. TiPS 7:506-511.
2. Arauja, D.M., Lapchak, P.A., Robitaille, Y., Gauthier, S. and Quirion, R. (1988). Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50:19114-1923.
3. Bachmann, C. and Colombo, J.P. (1984). Increase of tryptophan and 5-hydroxyindoleacetic acid in the brain of ornithine carbamoyl transferase deficient sparse-fur mice. Pediatr. Res. 18:372-375.
4. Bakker, M.H.M. and Foster, A.C. (1991). An investigation of the mechanisms of delayed neuron degeneration caused by direct injection of quinolinic acid into the rat striatum in vivo. Neuroscience 42:387-395.
5. Bassi S., Ferrarese, C., Finola, M.G., Frattola, L., Iannucelli, M., Meregalli, S. et al. (1988). L-acetyl-carnitine in Alzheimer Disease (AD) and Senile Dementia of the Alzheimer Type (SDAT), in Senile Dementias (Second International Symposium) (A. Agnoli, J. Cahn, N. Larsen and R. Mayeux, eds.), John Libbey Eurotext, Paris, pp. 461-466.
6. Batshaw, M.L., Robinson, M.B., Hyland, K., Djali, S. and Heyes, M.P. (1993). Quinolinic acid in children with congenital hyperammonemia. Ann. Neurol. 34:676-681.
7. Batshaw, , ML., Hyman, S.L., Coyle, J.T., Robinson, M.B., Qureshi, I.A., Millits, E.D., and Quaskey, S. (1988). Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse. Pediatr. Res. 23:368-374.
8. Broelsch, E.C., Emond, J.C., Whitington, P.F., Thistlethwaite, J.R., Baker, A.L., and Lichtor, J.L. (1990). Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and liver related segmental transplants. Ann. Surg. 212:368-375.
9. Brusilow, S.W. and Horwich, A.L. (1995). Urea cycle enzymes. In (C.R. Scriver, A.L. Beaudet, W.S. Sly et al. (eds.) The Metabolic and Molecular Basis of Inherited Disease, 7th Ed. New York: McGraw-Hill Information Services, pp. 1187-1232.
10. Brusilow, S.W., Valle, D.L., and Batshaw, M. (1979). New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2:452-454.
11. Chaouloff, F., Laude, D., Mignot, E., Kamoun, P., and Elghozi, J.L. (1985). Tryptophan and serotonin turnover rate in the brain of genetically hyperammonemic mice. Neurochem. Int. 7:143-153.
12. Christodoulou, J., Qureshi, I.A., McInnes, R.F. and Clarke, J.T.R. (1993). Ornithine transcarbamylase deficiency presenting with stroke-like episodes. J. Pediatr. 122:423-425.
13. Colombo, J.P. (1971). Congenital disorders of the urea cycle and ammonia detoxification. Monogr. Paediatr. 1, Karger. Basel.
14. Connelly, A., Cross, J.H., Gadian, D.G., Hunter, J.V., Kirkham, F.J., and Leonard, J.V. (1993). Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr. Res. 33:77-81.
15. Demars, R., Levan, S.L., Trend, B.L., and Russel, L.B. (1976). Abnormal ornithine carbamyl transferase in mice having the sparse-fur mutation. Proc. Natl. Acad. Sci. USA 23:1693-1698.
16. Dolman, C.L. Clasen, R.A., and Dorovini-Zis K. (1988). Severe cerebral damage in ornithine transcarbamylase deficiency. Clin. Neuropathol. 7:10-15.
17. Filloux, F., Townsend, J.J., and Leonard, C. (1986). Ornithine transcarbamylase deficiency: neuropathologic changes acquired in utero. J. Pediat. 108:942-945.
18. 3H-PK11195 in rat brain following portacaval anastomosis. Brain Res. 585:295-298.
19. Harding, B.N., Leonard, J.V., and Erdohazi, M. (1984). Ornithine transcarbamylase deficiency: neuropathological study. Eur. J. Pediatr. 141:215.
20. Harper, C.G. and Butterworth, R.F. (1997). Nutritional and metabolic disorders in. (D.I. Graham and P.L. Lantos, eds) Greenfield's Neuropathology, Arnold, London, UK, 1997, pp. 601-655.
21. Hasegawa, T., Tzakis, A.G., Todo, S., Reyes, J., Nour, B., Finegold, D.N. et al. (1995). Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J. Pediat. Surg. 30:863-865.
22. Hyman. S.L., Porter, C.A., Page, J.J., Iwata, B.A., Kissel, R., and Batshaw, M.L. (1988). Behavioral management of feeding disturbances in urea cycle and organic acid disorders. J. Pediatr. 111:558-562.
23. Inoue, I., Shimizu, T., Saheki, T., Noda, T., and Fukuda, T. (1989). Serotonin- and catecholamine-related substances in the brain of ornithine transcarbamylase-deficient sparse-fur mice in the hyperammonemic state: comparison of two procedures for obtaining brain extract, decapitation and microwave irradiation. Biochem. Med. Metab. Biol. 42:232-239.
24. Inui, A., Fujisawa, T., Komatsu, H., Tanaka, K., and Inui, M. (1996). Histological improvement in native liver after auxiliary partial liver transplantation for ornithine transcarbamylase deficiency [letter]. Lancet 348:751-752.
25. Kalbag, S.S. and Palekar, A.G. (1988). Sodium benzoate inhibits fatty acid oxidation in rat liver. Effect on ammonia levels. Biochem. Med. Metab. Biol. 40:133-142.
26. Kendall, B.E., Kingsley, D.P.E., Leonard, J.V., Lingam, S., and Oberholzer, V.G. (1983). Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency. J. Neurol. Neurosurg. Psychiatry 46:28-34.
27. Lai, J.C.K. and Cooper, A.J.L. (1986). Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution and effects of inhibitors. J Neurochem. 47:1376-1386.
28. Lavoie, J., Pomier Layrargues, G., and Butterworth, R.F. (1990). Increased densities of "peripheral-type" benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy Hepatology 11:874-878.
29. Matsuoka, M., Igisu, H., Kohriyama, K., and Inoue, N. (1991). Suppression of neurotoxicity of ammonia by L-carnitine. Brain Res. 567:328-331.
30. Matsuoka, M. and Igisu, H. (1993). Effects of L- and D-carnitine on brain energy metabolites in mice given sublethal doses of ammonium acetate. Pharmacol. & Toxicol. 72:145-147.
31. Michalak, A. and Qureshi, I.A. (1995a). Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate. Biochem. and Molec. Med. 54:96-104.
32. Michalak, A. and Qureshi, I.A. (1995b). Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine. Biomed. & Pharmacother. 49:350-357.
33. Morsy, M.A. and Caskey, C.T. (1994). Ornithine transcarbamylase deficiency: a model for gene therapy. In (V. Felipo and S. Grisolia, eds.) Hepatic Encephalopathy, Hyperammonemia and Ammonia Toxicity, Plenum Press, New York, pp. 145-154.
34. Msall, M., Batshaw, M.L., Suss, R., Brusilow, S.W., and Mellits, E.D. (1984). Neurologic outcome in children with inborn errors of urea synthesis. New Engl. J. Med. 310:1500-1505.
35. O'Connor, J.E., Costell, M., Miguez, M.P., and Grisolia, S. (1986). Influence of the route of administration on the protective effect of L-carnitine on acute hyperammonemia. Biochem. Pharmacol. 35:3173-3176.
36. Qureshi, I.A. (1992). Animal models of hereditary hyperammonemias. In: (A. Boulton, G. Baker, and R. Butterworth, eds.) Neuromethods, Vol. 22: Animal Models of Neurological Disease, II, Humana Press, Clifton N.J. pp. 329-356.
37. 3H]PK11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse. Pediatr. Res. 34:777-780.
38. Raghavendra Rao, V.L., Qureshi, I.A., and Butterworth, R.F. (1994). Activities of monoamine oxidase-A and -B are altered in the brains of congenitally hyperammonemic sparse-fur (spf) mice. Neurosci. Lett. 170:27-30.
39. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1992). Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem. Biophys. Res. Commun. 184:746-751.
40. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1993a). Evidence for a severe cholinergic neuronal deficit in brain in congenital ornithine transcarbamylase (OTC) deficiency. Soc. Neurosci. Abs. 19:122.
41. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1993b). Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia. Biochem. Pharmacol. 45:137-146.
42. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1993c). Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fuce mice and its role during benzoate therapy. Metabolism 42:1039-1046.
43. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1994a). Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 9:43-51.
44. Ratnakumari, L., Qureshi, I.A., and Butterworth, R.F. (1994b). Evidence for cholinergic neuronal loss in brain in congenital ornithine transcarbamylase deficiency. Neurosci. Lett. 178:63-65.
45. Ratnakumari, L., Qureshi, I.A., Maysinger, D., and Butterworth, R.F. (1995a). Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine. J Pharmacol. Exp. Ther. 274:437-443.
46. 3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 10:249-255.
47. Ratnakumari, L., Qureshi, I.A., Butterworth, R.F., Marescau, B., and De Deyn, P.P. (1996a). Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency. In (P.P. De Deyn et al., eds.) Guanidino Compounds, John Libby and Co., pp. 17-20.
48. 2 receptor changes in congenital ornithine transcarbamylase deficiency. Pediat. Res. 40:25-28.
49. Robinson, M.B., Hopkins, K., Batshaw, M.L., McLaughlin, B.A., Heyes, M.P., and Oster-Granite, M.L. (1995a). Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Dev. Brain Res. 90:35-44.
50. Robinson, M.B., Batshaw, M.L., Ye, X., and Wilson, J.M. (1995b). Prospects for gene therapy in ornithine carbamoyltransferase deficiency and other urea cycle disorders. MRDS Res. Rev. 1:62-70.
51. 1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. J. Neurochem. 58: 1016-10222.
52. Robinson, M.B., Heyes, M.P., Anegawa, N.J. et al. (1992b). Quinolinate in brain and cerebrospinal fluid in rat models of congenital hyperammonemia. Pediatr. Res. 32:483-488.
53. Schwarcz, R., Whetsell, W.O., Jr., and Mangano, R.M. (1983). Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316-318.
54. A receptor by steroids. Seminars in Neurosci. 3:231-29.
55. Takayanagi, M., Ohtake, A., Ogura, N., Nakajima, H., and Hoshino, M. (1984). A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Brain Dev. 6:58.
56. Todo, S., Starzl, T.E., Tzakis, A., Benkov, K.J., Kalousek, F., Saheki, T., Tanikawa, K., and Fenton, W.A. (1992). Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15:419-422.
57. Tucek, S. (1985). Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44:11-24.
58. Tuchman, M., Plante, R.J., Garcia-Perez, M.A. and Rubio, V. (1996). Relative frequency of mutation causing ornithine transcarbamylase deficiency in 78 families. Human Genetics 97:274-276.
59. Veres, G. Gibbs, R.A., Scherer, S.E. and Caskey, C.T. (1987). The molecular basis of the sparse fur mutation. Science 237:415-417.
60. Ye, X., Robinson, M.B., Batshaw, M.L., Furth, E.E., Smith, I. and Wilson, J.M. (1996). Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271:3639-3646.